Protagenic Therapeutics Stock (NASDAQ:PTIX)
Previous Close
$0.87
52W Range
$0.50 - $1.98
50D Avg
$0.71
200D Avg
$1.02
Market Cap
$3.53M
Avg Vol (3M)
$221.35K
Beta
0.28
Div Yield
-
PTIX Company Profile
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.